References
Torres-Ruiz J, Rull-Gabayet M, Mejía-Domínguez NR, Carrillo-Vázquez DA, Reyes-Islas JA, Cassiano-Quezada F et al (2024) Disease activity is associated with changes in the innate immune function in patients with systemic lupus erythematosus. Clin Rheumatol 43:501–509
Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN et al (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78:736–745
Md Yusof MY, Smith EMD, Ainsworth S, Armon K, Beresford MW, Brown M et al (2023) Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope. Rheumatol Adv Pract 7:rkad093
Parise-Fortes MR, Marques SA, Soares AM, Kurokawa CS, Marques ME, Peracoli MT (2006) Cytokines released from blood monocytes and expressed in mucocutaneous lesions of patients with paracoccidioidomycosis evaluated before and during trimethoprim-sulfamethoxazole treatment. Br J Dermatol 154:643–650
Acknowledgements
The authors appreciate the encouragement of the members in the Department of Ultrasound Medicine, Zhejiang Provincial People’s Hospital.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Consent from all authors
All authors reviewed this manuscript and agreed to submit this manuscript.
Competing interests
We declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dai, W., He, H. Regarding the association between innate immune function with disease activity in systemic lupus erythematosus patients. Clin Rheumatol 43, 1417–1418 (2024). https://doi.org/10.1007/s10067-024-06894-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-024-06894-8